In a large dataset comprising gene expression data from 2487 pediatric cancer patients23, CDK12 expression was slightly but significantly higher in AML patients (n = 320) compared to all other pediatric cancer entities (Fig. 6A). The gene discussed is CDK12; the disease is acute myeloid leukemia.